FRESENIUS MEDICAL CARE AG shares fell nearly 6% Tuesday morning after reporting a 0.4% decline in United States treatment volumes. This marks the second consecutive quarter of shrinking U.S. volumes for the Germany-based dialysis provider. Investors are weighing persistent volume weakness against the company's ongoing profitability overhaul and 2026 outlook confirmation.
Fresenius Medical Care Shares Fall on Lower US Volumes
FMC shares fell 6% as U.S. dialysis volumes declined for a second quarter. Revenue fell to 4.61 billion euros amid currency impacts and transformation costs.
Xurve View
洞察:
Xurve View










